211 related articles for article (PubMed ID: 23966747)
1. Multicentric Castleman's disease in a Ghanaian adult.
Dei-Adomakoh YA; Segbefia C; Ekem I; Taylor A
Ghana Med J; 2013 Jun; 47(2):92-5. PubMed ID: 23966747
[TBL] [Abstract][Full Text] [Related]
2. Multicentric Castleman's disease in two cases.
Sharma R; Seth R; Thavaraj V; Bagga A; Kabra SK; Karak AK; Atri S
Indian J Pediatr; 2007 Dec; 74(12):1116-20. PubMed ID: 18174650
[TBL] [Abstract][Full Text] [Related]
3. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
[TBL] [Abstract][Full Text] [Related]
4. Multicentric Castleman's disease.
Herrada J; Cabanillas FF
Am J Clin Oncol; 1995 Apr; 18(2):180-3. PubMed ID: 7900713
[No Abstract] [Full Text] [Related]
5. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
[TBL] [Abstract][Full Text] [Related]
6. A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman's disease).
Pavlidis NA; Skopouli FN; Bai MC; Bourantas CL
Med Pediatr Oncol; 1990; 18(4):333-5. PubMed ID: 2355894
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.
Flejsierowicz M; Ahmed MS; Kotov P; Cheng YC
WMJ; 2008 Jul; 107(4):191-4. PubMed ID: 18702436
[TBL] [Abstract][Full Text] [Related]
8. Unusual case of multicentric mixed-type Castleman's disease presenting with exfoliative dermatitis.
Yalcin AD; Keskin A; Erdogan BS; Hekimgil M
Int J Dermatol; 2004 Mar; 43(3):202-5. PubMed ID: 15009392
[No Abstract] [Full Text] [Related]
9. Multicentric Castleman's disease in a renal allograft recipient: a case report and literature review.
Lin J; Yu S; Wang R; Chen J
J Int Med Res; 2020 Feb; 48(2):300060519897481. PubMed ID: 32046545
[TBL] [Abstract][Full Text] [Related]
10. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.
Cervera Grau JM; Galiana Esquerdo G; Llorca Ferrándiz C; Briceño García H; Díaz Castellano M; Férriz Moreno P
Clin Transl Oncol; 2006 Jul; 8(7):540-1. PubMed ID: 16870545
[TBL] [Abstract][Full Text] [Related]
11. A patient with Castleman's disease mimicking acute pancreatitis.
Wu J; Lv L; Wang C
Rev Esp Enferm Dig; 2017 Oct; 109(10):737-738. PubMed ID: 28929773
[TBL] [Abstract][Full Text] [Related]
12. Multicentric Castleman's disease manifesting in the lung: clinical, radiographic, and pathologic findings and successful treatment with corticosteroid and cyclophosphamide.
Iyonaga K; Ichikado K; Muranaka H; Fujii K; Yamaguchi T; Suga M
Intern Med; 2003 Feb; 42(2):182-6. PubMed ID: 12636239
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of rituximab in patients with HIV related lymphoma and Multicentric Castleman's disease.
Reid E; Nooka A; Blackmon J; Lechowicz MJ
Curr Drug Deliv; 2012 Jan; 9(1):41-51. PubMed ID: 22023215
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and outcome of patients with HIV-negative multicentric Castleman's disease treated with combination chemotherapy: a report on 10 patients.
Zhu SH; Yu YH; Zhang Y; Sun JJ; Han DL; Li J
Med Oncol; 2013 Mar; 30(1):492. PubMed ID: 23400962
[TBL] [Abstract][Full Text] [Related]
15. Sjögren's and plasma cell variant Castleman disease: a case report.
Dei-Adomakoh YA; Quarcoopome L; Abrahams AD; Segbefia CI; Dey DI
Ghana Med J; 2018 Mar; 52(1):61-65. PubMed ID: 30013261
[TBL] [Abstract][Full Text] [Related]
16. Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions.
Mochizuki H; Kato M; Higuchi T; Koyamada R; Arai S; Okada S; Eto H
Intern Med; 2017; 56(9):1095-1099. PubMed ID: 28458319
[TBL] [Abstract][Full Text] [Related]
17. Castleman's disease: from basic mechanisms to molecular therapeutics.
El-Osta HE; Kurzrock R
Oncologist; 2011; 16(4):497-511. PubMed ID: 21441298
[TBL] [Abstract][Full Text] [Related]
18. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
[TBL] [Abstract][Full Text] [Related]
19. Frontline Siltuximab and Rituximab in TAFRO syndrome: A case report.
Marchetti M; Feyles E; Zinzani P
Eur J Haematol; 2020 Oct; 105(4):505-507. PubMed ID: 32564425
[No Abstract] [Full Text] [Related]
20. Successful treatment of multicentric Castleman's disease with bilateral orbital tumour using rituximab.
Ide M; Ogawa E; Kasagi K; Kawachi Y; Ogino T
Br J Haematol; 2003 Jun; 121(5):818-9. PubMed ID: 12780800
[No Abstract] [Full Text] [Related]
[Next] [New Search]
